Metlife Inc. buy Barclays PLC
Summary
This prediction is currently active. The price of Metlife Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.07%. This prediction currently runs until 07.02.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Metlife Inc. | -1.604% | -1.604% |
| iShares Core DAX® | -0.693% | 2.143% |
| iShares Nasdaq 100 | -1.173% | 1.632% |
| iShares Nikkei 225® | -1.388% | 2.138% |
| iShares S&P 500 | -1.411% | 0.648% |
Comments by Barclays_PLC for this prediction
In the thread Metlife Inc. diskutieren